Vontier Corp VNT 深 沪
已收盘 02-06 16:00:00 美东时间
42.10
+1.840
+4.57%
华盛通- 最 高42.26
- 今 开39.93
- 成交量 126.39万股
- 最 低 39.93
- 昨 收 40.26
- 总市值 61.09亿
- 52周最高 43.855
- 市盈率 静 15.34
- 换手率 0.87%
- 52周最低 27.145
- 委 比 -28.86%
- 总股本 1.45亿
- 历史最高 45.445
- 量 比 0.84
- 振 幅 5.79%
- 历史最低 16.225
- 每 手 1
- 风险率 3.56%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Vontier Executives to Present at Major Investor Conferences
Vontier Executives to Present at Major Investor Conferences Vontier Corporation announced that its President and CEO Mark Morelli, along with Senior Vice President and CFO Anshooman Aga, will present at two upcoming investor conferences. The company will participate in Citi's Global Industrial Tech
02-03 21:31
Vontier nimmt an wichtigen Investorenkonferenzen teil
Vontier nimmt an wichtigen Investorenkonferenzen teil Vontier Corporation wird am 17. Februar am Citi's Global Industrial Tech and Mobility Conference sowie am 18. Februar an der Barclays Industrial Select Conference teilnehmen. Disclaimer: This news brief was created by Public Technologies (PUBT) u
02-03 21:31
Vontier Corporation to Announce Earnings Results and Hold Conference Call
Vontier Corporation to Announce Earnings Results and Hold Conference Call Vontier Corporation will release its fourth quarter and full year 2025 earnings results on Thursday, February 12, 2026. A conference call to discuss the results will be held the same day at 8:30 a.m. ET. The results and webcas
01-22 21:31
How Is The Market Feeling About Vontier Corp?
Vontier Corp's (NYSE:VNT) short interest as a percent of float has risen 40.08%...
2025-11-29 04:00
美股大行评级 | 花旗上调Bilibili目标价升至27美元； 摩根士丹利上调英伟达目标价升至220美元；Ardent Health、Stubhub遭多家大行下调评级
花旗上调Bilibili目标价升至27美元； 摩根士丹利上调英伟达目标价升至220美元；Ardent Health、Stubhub遭多家大行下调评级>>
2025-11-17 10:49
B of A Securities Downgrades Vontier to Underperform, Lowers Price Target to $40
B of A Securities analyst Andrew Obin downgrades Vontier (NYSE:VNT) from Buy to Underperform and lowers the price target from $50 to $40.
2025-11-14 19:36
美股大行评级 | 高盛上调英伟达目标价升至240美元； Loop Capital上调英伟达目标价升至350美元！
今日重点评级关注：花旗：维持Caribou Biosciences"买入"评级，目标价从5美元升至8美元；HC Wainwright & Co.：上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入"，目标价30美元
2025-11-04 10:31
美股大行评级 | 苹果、亚马逊、Cloudflare、西部数据、Twilio等获十多家机构集体上调目标价；杰富瑞首予Cloudflare"持有"评级，目标价250美元
今日重点评级关注：康托·菲茨杰拉德：维持Cabaletta Bio"超配"评级，目标价从15美元升至30美元；HC Wainwright & Co.：维持Invivyd"买入"评级，目标价从5美元升至10美元
2025-11-03 20:20
Keybanc Maintains Overweight on Vontier, Lowers Price Target to $45
Keybanc analyst Ken Newman maintains Vontier (NYSE:VNT) with a Overweight and lowers the price target from $50 to $45.
2025-10-31 21:14
Vontier shares are trading lower after the company reported Q3 financial results and issued Q4 sales guidance below estimates. Also, the company narrowed its FY25 sales guidance below estimates.
Vontier shares are trading lower after the company reported Q3 financial result...
2025-10-31 01:42
